If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Wednesday, January 23, 2019 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News

Med Life S.A. - M

Completion of Ghencea Medical Center acquisition

Release Date: 5/24/2018 6:48:05 PM

IRIS Code: D3BC6


MedLife has completed the acquisition of Ghencea Medical Center



Bucharest, May 24, 2018: MedLife, the leader of the Romanian private medical services market, announces that it has completed the acquisition of the 90% stake in Ghencea Medical Center in Bucharest.


Ghencea Medical Center, with a 10-year activity on the market, registered a turnover of RON 8.7 million last year, while for this year it is counting on a 20% increase. The medical services provider consists of two clinics in Bucharest and Magurele, with 135 employees, medical professionals and support staff, offering patients a diverse range of investigations for laboratory and imaging areas, specialized treatment for medical recovery and alternative medicine.

At the same time, Ghencea Medical Center is one of the relevant providers of medical services in contract with the Bucharest Health Insurance House (CASMB), covering over 25 specialties, including occupational health medicine, pediatrics, rheumatology, gastroenterology, neurology, cardiology, psychiatry, urology, dermatology and ENT.

MedLife reported the end of the first quarter of 2018 on an upward trend and announced a pro-forma consolidated turnover of RON 196.8 million for this period, up by 34% over the same period last year. For 2017, pro-forma consolidated turnover was of RON 638 million, up by 27% as compared to 2016 and an adjusted pro-forma EBITDA of RON 82.3 million.


About MedLife:


MedLife is the largest private medical operator in Romania. The company operates the largest network of clinics, one of the major networks of medical laboratories, multi and monodisciplinary hospitals and it has the largest client base for Health Prevention Packages at national level. Also, sales-wise, it is one of the major private healthcare companies in Central and Eastern Europe.

The stock issued by MedLife SA is accepted for trading on the spot regulated market, managed by the Bucharest Stock Exchange, under the Premium Category, ticker symbol “M”.

The MedLife Group has a successful background regarding both organic and also acquisition growth. Since 2009 the company has opened or bought over 83 medical units. Its strong and experienced management team has been able to create and manage these growth opportunities, acquiring valuable experiences and knowledge, allowing it to find the best way for carrying on the expansion process successfully.



Information provided by IRIS, the news platform of the Bucharest Stock Exchange.


Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

©2016 Bucharest Stock Exchange. All rights reserved